Results
Neurocrine Beats Q1 Forecast, Shares Jump 8%
Neurocrine reported Q1 adjusted earnings of $1.94 per share, surpassing the $1.17 consensus by $0.77 for the quarter.
Revenue reached $811.0 million, topping the $766.85 million forecast and marking a
